Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The Senior Director, Epidemiology will lead the epidemiology strategy for a given asset and/or indication, including developing plans for epidemiology deliverables, designing and executing deliverables in accordance with the plan, and providing epidemiology leadership to Clinical Development, Global Patient Safety, Regulatory Affairs, Medical Affairs, and Commercial activities across the medicines development life cycle.
Requirements
- PhD / DSc / DrPH in epidemiology or a relevant advanced science degree
- At least 12 years of related industry experience at a sponsor/pharmaceutical company
- Demonstrated technical knowledge of pharmacoepidemiologic methods and real-world oncology data sets
- History of publications demonstrating the successful design, execution and communication of epidemiologic research
- Knowledge of drug and clinical development process for genomic/targeted medicines
- Excellent analytic and problem-solving skills
- Excellent attention to detail and quality, and scientific rigor
- Strong interpersonal skills and the ability to work effectively in multidisciplinary teams
- Existing external relationships to foster collaborative and timely research
Benefits
- Competitive cash compensation
- Robust equity awards
- Strong benefits
- Significant learning and development opportunities